aap Implantate AG (AAQ1.DE)
EUR 1.33
(-6.34%)
EUR 1.33
(-6.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.16 Million EUR | -52.93% |
| 2022 | -3.24 Million EUR | -20.4% |
| 2021 | -2.69 Million EUR | 64.6% |
| 2020 | -7.6 Million EUR | -5.09% |
| 2019 | -7.23 Million EUR | 11.06% |
| 2018 | -8.13 Million EUR | -1.73% |
| 2017 | -7.99 Million EUR | 21.49% |
| 2016 | -10.18 Million EUR | -16.99% |
| 2015 | -8.7 Million EUR | -16016.67% |
| 2014 | -54 Thousand EUR | -107.51% |
| 2013 | 719 Thousand EUR | -77.62% |
| 2012 | 3.21 Million EUR | 175.71% |
| 2011 | 1.16 Million EUR | 62.03% |
| 2010 | 719 Thousand EUR | -80.03% |
| 2009 | 3.6 Million EUR | 177.67% |
| 2008 | -4.63 Million EUR | -120.19% |
| 2007 | -2.1 Million EUR | -198.7% |
| 2006 | 2.13 Million EUR | 664.39% |
| 2005 | 279 Thousand EUR | -59.32% |
| 2004 | 685.76 Thousand EUR | 271.63% |
| 2003 | -399.55 Thousand EUR | -109.01% |
| 2002 | 4.43 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -910 Thousand EUR | 28.23% |
| 2023 Q2 | -948 Thousand EUR | -4.18% |
| 2023 FY | -4.95 Million EUR | -52.93% |
| 2022 Q4 | -1.26 Million EUR | 0.0% |
| 2022 FY | -3.24 Million EUR | -20.4% |
| 2022 Q1 | -888 Thousand EUR | 13.45% |
| 2022 Q2 | -618 Thousand EUR | 30.41% |
| 2022 Q3 | -1.26 Million EUR | -105.18% |
| 2021 Q1 | -641 Thousand EUR | -110.16% |
| 2021 FY | -2.69 Million EUR | 64.6% |
| 2021 Q2 | -167 Thousand EUR | 73.95% |
| 2021 Q3 | -1.02 Million EUR | -514.37% |
| 2021 Q4 | -1.02 Million EUR | 0.0% |
| 2020 Q4 | -305 Thousand EUR | 0.0% |
| 2020 Q3 | -305 Thousand EUR | 91.14% |
| 2020 FY | -7.6 Million EUR | -5.09% |
| 2020 Q2 | -3.44 Million EUR | -28.0% |
| 2020 Q1 | -2.68 Million EUR | -14.35% |
| 2019 Q2 | -2.73 Million EUR | -74.49% |
| 2019 Q3 | -2.35 Million EUR | 14.05% |
| 2019 FY | -7.23 Million EUR | 11.06% |
| 2019 Q1 | -1.56 Million EUR | 32.06% |
| 2019 Q4 | -2.35 Million EUR | 0.0% |
| 2018 Q3 | -1.91 Million EUR | 1.84% |
| 2018 FY | -8.13 Million EUR | -1.73% |
| 2018 Q2 | -1.95 Million EUR | 2.3% |
| 2018 Q1 | -1.99 Million EUR | -19.35% |
| 2018 Q4 | -2.3 Million EUR | -20.46% |
| 2017 FY | -7.99 Million EUR | 21.49% |
| 2017 Q2 | -2.12 Million EUR | 1.16% |
| 2017 Q4 | -1.67 Million EUR | 18.1% |
| 2017 Q3 | -2.04 Million EUR | 3.86% |
| 2017 Q1 | -2.15 Million EUR | 27.94% |
| 2016 Q2 | -1.86 Million EUR | 29.69% |
| 2016 Q1 | -2.65 Million EUR | 58.71% |
| 2016 FY | -10.18 Million EUR | -16.99% |
| 2016 Q4 | -2.98 Million EUR | -11.55% |
| 2016 Q3 | -2.67 Million EUR | -43.41% |
| 2015 Q2 | -1.47 Million EUR | -235.08% |
| 2015 Q3 | -365 Thousand EUR | 75.19% |
| 2015 Q4 | -6.42 Million EUR | -1661.1% |
| 2015 FY | -8.7 Million EUR | -16016.67% |
| 2015 Q1 | -439 Thousand EUR | 47.17% |
| 2014 Q2 | 962 Thousand EUR | 324.77% |
| 2014 FY | -54 Thousand EUR | -107.51% |
| 2014 Q4 | -831 Thousand EUR | -441.98% |
| 2014 Q3 | 243 Thousand EUR | -74.74% |
| 2014 Q1 | -428 Thousand EUR | 80.82% |
| 2013 Q4 | -2.23 Million EUR | -801.89% |
| 2013 FY | 719 Thousand EUR | -77.62% |
| 2013 Q1 | 2.3 Million EUR | 198.32% |
| 2013 Q2 | 328 Thousand EUR | -85.78% |
| 2013 Q3 | 318 Thousand EUR | -3.05% |
| 2012 Q4 | 773 Thousand EUR | 63.08% |
| 2012 FY | 3.21 Million EUR | 175.71% |
| 2012 Q1 | 1.31 Million EUR | 220.15% |
| 2012 Q2 | 646 Thousand EUR | -51.02% |
| 2012 Q3 | 474 Thousand EUR | -26.63% |
| 2011 Q1 | 87 Thousand EUR | 133.85% |
| 2011 Q4 | 412 Thousand EUR | 724.0% |
| 2011 FY | 1.16 Million EUR | 62.03% |
| 2011 Q3 | 50 Thousand EUR | -91.88% |
| 2011 Q2 | 616 Thousand EUR | 608.05% |
| 2010 FY | 719 Thousand EUR | -80.03% |
| 2010 Q2 | 574 Thousand EUR | 205.9% |
| 2010 Q1 | -542 Thousand EUR | -288.85% |
| 2010 Q3 | 946 Thousand EUR | 64.81% |
| 2010 Q4 | -257 Thousand EUR | -127.17% |
| 2009 Q4 | 287 Thousand EUR | -92.21% |
| 2009 FY | 3.6 Million EUR | 177.67% |
| 2009 Q3 | 3.68 Million EUR | 981.58% |
| 2009 Q2 | -418 Thousand EUR | -1008.7% |
| 2009 Q1 | 46 Thousand EUR | 0.0% |
| 2008 Q2 | 986 Thousand EUR | 0.0% |
| 2008 FY | -4.63 Million EUR | -120.19% |
| 2007 FY | -2.1 Million EUR | -198.7% |
| 2006 FY | 2.13 Million EUR | 664.39% |
| 2005 FY | 279 Thousand EUR | -59.32% |
| 2004 FY | 685.76 Thousand EUR | 271.63% |
| 2003 FY | -399.55 Thousand EUR | -109.01% |
| 2002 FY | 4.43 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 103.02% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 103.02% |
| elexxion AG | -417.66 Thousand EUR | -1137.604% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 46.99 Million EUR | 110.999% |
| Geratherm Medical AG | 2.21 Million EUR | 332.92% |
| Koninklijke Philips N.V. | -115 Million EUR | 95.505% |
| Stratec SE | 22.88 Million EUR | 122.584% |
| Siemens Healthineers AG | 2.86 Billion EUR | 100.18% |